Ticker
$HSCS
1 catalyst touching HSCS in the last 60 days, newest first, each with the price move that followed.
- 72
HeartSciences MyoVista wavECG receives FDA 510(k) clearance
HeartSciences announced FDA 510(k) clearance (K260005) for its MyoVista wavECG device as a 12-lead resting electrocardiograph. The clearance removes a regulatory hurdle for commercializing the device and adds credibility to the company's technology in advance of its pending business combination with Fortitude Mining Holdings, potentially improving deal valuation or completion odds.
HSCS ▲SEC 8-K · 6 Oct 2026, 20:30 UTC
Information only. AURA does not give buy or sell recommendations.